Condition
Gastroesophageal Cancer (GC) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Gastroesophageal Cancer (GC) clinical trials that are recruiting, at sites in 3 countries (most in United States (3), Sweden (1), Denmark (1)). By phase: Phase 1 (2), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Gastroesophageal Cancer (GC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BEFAST: Total Body PET/CT with Ga-68 FAPI for Better Imaging in Cancer | Phase 2 | Copenhagen | Recruiting | Jun 5, 2026 |
| BHB810 in advanced gastric and GEJ cancer (early-phase) | Phase 1/2 | Duarte, California and 2 other locations | Recruiting | Apr 14, 2026 |
| Phase 1 safety and tolerability testing of CTX-10726 in advanced cancers. | Phase 1 | Phoenix, Arizona and 7 other locations | Recruiting | Feb 19, 2026 |
| IDE892 alone and with IDE397 for MTAP-deleted advanced solid tumors | Phase 1 | Goodyear, Arizona and 22 other locations | Recruiting | Dec 11, 2025 |
| Cognitive effects of stomach or esophagus cancer surgery | — | Huddinge | Recruiting | Nov 13, 2024 |
All recruiting trials (5)
-
BEFAST: Total Body PET/CT with Ga-68 FAPI for Better Imaging in Cancer
This study tests whether Ga-68 FAPI-46 Total Body PET/CT can better detect cancer spread and provide fast, clear images for adults with pancreatic or gastroesophageal cancer.
-
BHB810 in advanced gastric and GEJ cancer (early-phase)
This study tests whether BHB810 can be safely given every two weeks to adults with advanced gastric or GEJ adenocarcinoma and looks at its effect, how the drug behaves in the body, and patient responses.
-
Phase 1 safety and tolerability testing of CTX-10726 in advanced cancers.
This phase 1 trial will test whether CTX-10726 given by IV every two weeks is safe and tolerable for adults with advanced or metastatic renal cell carcinoma, hepatocellular carcinoma, endometrial, or gastroesophageal cancer who have exhausted standard treatments.
-
IDE892 alone and with IDE397 for MTAP-deleted advanced solid tumors
This trial tests IDE892 by itself and combined with IDE397 in adults whose advanced solid tumors have MTAP deletion and have progressed after standard treatments.
-
Cognitive effects of stomach or esophagus cancer surgery
This study will see how often people who have surgery for stomach or esophagus cancer develop postoperative delirium and whether it is linked to preoperative depression, frailty, malnutrition, sarcopenia, or lower quality of life.
Related topics
Quick answers
How many Gastroesophageal Cancer (GC) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Sweden (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.